Provided by Tiger Trade Technology Pte. Ltd.

SOPHiA GENETICS SA

8.65
+0.32003.84%
Post-market: 8.680.0300+0.35%19:40 EDT
Volume:423.26K
Turnover:3.58M
Market Cap:736.36M
PE:-7.46
High:8.68
Open:8.34
Low:8.15
Close:8.33
52wk High:8.68
52wk Low:3.10
Shares:85.13M
Float Shares:65.29M
Volume Ratio:0.75
T/O Rate:0.65%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1597
EPS(LYR):-1.1700
ROE:-101.22%
ROA:-24.52%
PB:8.86
PE(LYR):-7.39

Loading ...

Sophia Genetics Launches Proposed Share Offering

MT Newswires Live
·
Jun 17

SOPHiA Genetics launches underwritten public offering of ordinary shares

Reuters
·
Jun 17

Sophia Genetics Chief Medical Officer Philippe Menu reports $24,752 disposal of common shares

Reuters
·
Jun 16

SOPHiA GENETICS Price Target Maintained With a $8.00/Share by BTIG

Dow Jones
·
Jun 15

SOPHiA GENETICS (SOPH) Receives a Buy from BTIG

TIPRANKS
·
Jun 15

Sophia Genetics CEO Jurgi Camblong sells 8,500 shares worth $44,501.09

Reuters
·
Jun 12

SOPHiA GENETICS Names Ross Muken as CEO, Nominates Jurgi Camblong as Chairman

MT Newswires Live
·
Jun 10

Sophia Genetics appoints Ross Muken as CEO

TIPRANKS
·
Jun 10

Sophia Genetics shareholders vote on board chair nomination at annual meeting

Reuters
·
Jun 10

Sophia Genetics CFO George Cardoza reports purchase of 20,000 shares for $99,000

Reuters
·
Jun 06

SOPHiA GENETICS Signs Strategic Collaboration MoU With Leading Global Cancer Center

Reuters
·
Jun 04

SOPHiA Genetics signs MOU with Memorial Sloan Kettering for planned precision oncology joint venture

Reuters
·
Jun 04

SOPHiA Genetics partners with ARC Regulatory to develop EU clinical trial assays

Reuters
·
Jun 01

Sophia Genetics Chief Medical Officer Philippe Menu disposes of 5,000 common shares worth $24,774

Reuters
·
Jun 01

Sophia Genetics CSO Zhenyu Xu sells 4,000 shares worth $18,168.40

Reuters
·
May 15

Sophia Genetics director Kathy Hibbs sells $35,037 of ordinary shares

Reuters
·
May 14

Sophia Genetics, Synnovis Partner on UK Blood-Based Cancer Testing

MT Newswires Live
·
May 13

SOPHiA Genetics partners with Synnovis to expand liquid biopsy cancer testing in UK

Reuters
·
May 13

Sophia Genetics CEO Jurgi Camblong sells 8,500 shares worth $43,241.20

Reuters
·
May 13

SOPHiA GENETICS (SOPH) Quarterly Losses Test Bullish Growth Narrative Despite Revenue Progress

Simply Wall St.
·
May 07